Hashimoto disease is an autoimmune disorder that affects the thyroid gland. It is a chronic condition that can cause a variety of symptoms, including fatigue, weight gain, depression, and dry skin. The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. In this article, we will explore the causes and treatments of Hashimoto disease.
Hashimoto disease is an autoimmune disorder in which the body’s immune system mistakenly attacks the thyroid gland. This causes the thyroid gland to become inflamed and unable to produce the hormones needed to regulate metabolism, heart rate, and body temperature. Over time, this can lead to an underactive thyroid, or hypothyroidism. Hashimoto disease is the most common cause of hypothyroidism in the United States. It is estimated that up to 2% of the population has the disease, and it is more common in women than men. It can occur at any age, but it is more likely to occur in people over the age of 40.
The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Genetics plays a role in the development of the disease, as it is more common in people who have a family history of the disorder. Environmental factors, such as exposure to certain viruses or toxins, may also play a role in the development of the disorder.
The symptoms of Hashimoto disease can vary from person to person, but they typically include fatigue, weight gain, depression, dry skin, and constipation. Other symptoms may include muscle aches, joint pain, and an enlarged thyroid gland, known as a goiter.
Hashimoto disease is typically diagnosed through a physical exam and a blood test. The blood test measures the levels of thyroid hormones and antibodies in the body. If the levels of these hormones and antibodies are abnormal, it is likely that the patient has Hashimoto disease.
Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. Medications, such as levothyroxine, can help to replace the hormones that the thyroid is not producing. In addition, lifestyle adjustments, such as eating a balanced diet, getting regular exercise, and reducing stress, can help to manage the symptoms of the disease.
Hashimoto disease is an autoimmune disorder that affects the thyroid gland. It is a chronic condition that can cause a variety of symptoms, including fatigue, weight gain, depression, and dry skin. The exact cause of Hashimoto disease is unknown, but it is believed to be linked to genetics and environmental factors. Treatment for Hashimoto disease typically involves medications and lifestyle adjustments to help manage the symptoms. By understanding the causes and treatments of Hashimoto disease, doctors can provide the best possible care for their patients.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation